TY - JOUR
T1 - Comparison of the BioRad Variant and Primus Ultra2 high-pressure liquid chromatography (HPLC) instruments for the detection of variant hemoglobins
AU - Gosselin, R. C.
AU - Carlin, A. C.
AU - Dwyre, Denis M
PY - 2011/4
Y1 - 2011/4
N2 - Introduction: Hemoglobin variants are a result of genetic changes resulting in abnormal or dys-synchronous hemoglobin chain production (thalassemia) or the generation of hemoglobin chain variants such as hemoglobin S. Automated high-pressure liquid chromatography (HPLC) systems have become the method of choice for the evaluation of patients suspected with hemoglobinopathies. Methods: In this study, we evaluated the performance of two HPLC methods used in the detection of common hemoglobin variants: Variant and Ultra2. Results: There were 377 samples tested, 26% (99/377) with HbS, 8.5% (32/377) with HbC, 20.7% (78/377) with other hemoglobin variant or thalassemia, and 2.9% with increased hemoglobin A1c. The interpretations of each chromatograph were compared. There were no differences noted for hemoglobins A0, S, or C. There were significant differences between HPLC methods for hemoglobins F, A2, and A1c. However, there was good concordance between normal and abnormal interpretations (97.9% and 96.2%, respectively). Conclusion: Both Variant and Ultra2 HPLC methods were able to detect most common hemoglobin variants. There was better discrimination for fast hemoglobins, between hemoglobins E and A2, and between hemoglobins S and F using the Ultra2 HPLC method.
AB - Introduction: Hemoglobin variants are a result of genetic changes resulting in abnormal or dys-synchronous hemoglobin chain production (thalassemia) or the generation of hemoglobin chain variants such as hemoglobin S. Automated high-pressure liquid chromatography (HPLC) systems have become the method of choice for the evaluation of patients suspected with hemoglobinopathies. Methods: In this study, we evaluated the performance of two HPLC methods used in the detection of common hemoglobin variants: Variant and Ultra2. Results: There were 377 samples tested, 26% (99/377) with HbS, 8.5% (32/377) with HbC, 20.7% (78/377) with other hemoglobin variant or thalassemia, and 2.9% with increased hemoglobin A1c. The interpretations of each chromatograph were compared. There were no differences noted for hemoglobins A0, S, or C. There were significant differences between HPLC methods for hemoglobins F, A2, and A1c. However, there was good concordance between normal and abnormal interpretations (97.9% and 96.2%, respectively). Conclusion: Both Variant and Ultra2 HPLC methods were able to detect most common hemoglobin variants. There was better discrimination for fast hemoglobins, between hemoglobins E and A2, and between hemoglobins S and F using the Ultra2 HPLC method.
KW - BioRad Variant
KW - Hemoglobinopathy
KW - High-pressure liquid chromatography
KW - Primus Ultra2
UR - http://www.scopus.com/inward/record.url?scp=79952475435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952475435&partnerID=8YFLogxK
U2 - 10.1111/j.1751-553X.2010.01260.x
DO - 10.1111/j.1751-553X.2010.01260.x
M3 - Article
C2 - 20840377
AN - SCOPUS:79952475435
VL - 33
SP - 159
EP - 167
JO - International Journal of Laboratory Hematology
JF - International Journal of Laboratory Hematology
SN - 1751-5521
IS - 2
ER -